Ticagrelor tablet is a prescription antiplatelet (blood-thinning) medication primarily used to prevent blood clots in individuals at high risk of cardiovascular events. Marketed under the brand name Brilinta, this medicine is often used in combination with other drugs to reduce the chances of heart attacks, strokes, or complications following heart-related surgeries. Ticagrelor 90 mg is a commonly prescribed dosage that helps maintain blood flow and prevent clot formation. Always use the ticagrelor tablet as directed by your healthcare provider.

What is Ticagrelor Tablet?

Ticagrelor tablet is a fast-acting blood thinner that works by preventing platelets in the blood from sticking together, which helps reduce the risk of dangerous clots. It is especially effective in patients who have had a heart attack, acute coronary syndrome (ACS), or are diagnosed with coronary artery disease (CAD).

What are the Uses of Ticagrelor 90 mg Tablets?

Ticagrelor helps prevent blood clots, reducing the risk of heart attacks, strokes, and other complications in people with heart conditions like acute coronary syndrome (ACS) and coronary artery disease (CAD). Ticagrelor 90 mg uses include maintaining blood flow in patients after a heart procedure or stent placement. Ticagrelor tablet uses also extend to preventing future cardiovascular events in high-risk individuals. It must be taken under medical supervision to avoid bleeding risks and ensure proper heart health management.

Conditions Ticagrelor Treats

  • Acute Coronary Syndrome (ACS)
  • Prevention of Heart Attack and Stroke
  • Coronary Artery Disease (CAD)
  • Transient Ischemic Attacks (TIA) or minor strokes

Secondary Uses of Ticagrelor

  • May be prescribed off-label for patients undergoing certain types of heart surgery to prevent clot formation.
  • Sometimes considered in patients with peripheral artery disease to reduce clot-related risks.
  • It may be used in select cases of stroke prevention when aspirin alone is not sufficient.
  • Occasionally considered in patients with a stent thrombosis history for long-term clot prevention.

How Does Ticagrelor 90 mg Tablet Work?

Ticagrelor belongs to a class of drugs called P2Y12 platelet inhibitors. It blocks a receptor on platelets, making it harder for them to clump together. This reduces the risk of blood clots forming in arteries, which is critical in preventing heart attacks and strokes. The ticagrelor 90 mg tablet works by maintaining consistent platelet inhibition throughout the day. Doctors often prescribe it after certain heart procedures or in patients with acute coronary syndrome to help reduce further cardiovascular risks.

Ticagrelor Dosage

The recommended ticagrelor 90 mg dosage is typically one tablet taken twice daily, along with a low-dose aspirin, as directed by a healthcare provider. This regimen is commonly used for patients with acute coronary syndrome or those who have had a stent placed in their arteries. The ticagrelor tablet dosage may vary based on individual health conditions and treatment goals. It is important to follow the prescribed dosage exactly to reduce the risk of blood clots and related complications.

Typical Dosage Instructions

  • Initial Dose: 180 mg orally (usually two 90 mg tablets)
  • Maintenance Dose: 90 mg taken twice daily
  • Can be taken with or without food.

Available Forms Strengths

  • Generic: Ticagrelor
  • Brand: Brilinta
  • Form: Oral Tablet
  • Strengths: 60 mg, 90 mg

What Should I Do If I Miss a Dose?

If you miss a dose of the ticagrelor tablet, take it as soon as you remember. However, if it's almost time for your next scheduled dose, skip the missed one. Do not take two doses at once to make up for it. Missing doses can reduce the medicine's effectiveness in preventing blood clots. Always follow your doctor's instructions carefully and try to take ticagrelor at the same time each day to maintain consistent protection.

What Happens in Case of an Overdose?

An overdose of the ticagrelor tablet may lead to excessive bleeding, including internal bleeding or prolonged bleeding from minor injuries. Symptoms like dizziness, shortness of breath, or vomiting blood may occur. In severe cases, urgent medical attention is required to manage bleeding risks. There is no specific antidote for a ticagrelor overdose, so supportive care is essential. If an overdose is suspected, seek emergency medical help immediately and do not attempt to treat it without professional supervision.

Symptoms may include:

  • Severe bleeding
  • Dizziness
  • Trouble breathing

Consult your healthcare provider before taking any medication. In case of a suspected overdose, seek emergency medical attention immediately.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

What are the Side Effects of Ticagrelor Tablets?

The side effects of ticagrelor tablets may include shortness of breath, dizziness, and an increased risk of bleeding, such as nosebleeds or bruising easily. Some patients may also experience headaches, nausea, or diarrhea. Serious side effects of ticagrelor 90mg tablets can involve internal bleeding or irregular heartbeat. It is important to report any unusual symptoms to your doctor. Always follow medical advice and monitor for adverse reactions when taking ticagrelor as part of your treatment plan.

Common Side Effects

  • Headache
  • Dizziness
  • Nausea or vomiting
  • Stomach pain
  • Diarrhea
  • Increased bleeding tendency
  • High uric acid levels

Serious Side Effects

  • Severe or unexplained bleeding
  • Difficulty breathing
  • Irregular heartbeat
  • Swelling in hands, feet, or ankles
  • Allergic reactions like rash, itching, or swelling of the face/lips

Important Precautions and Warnings for Ticagrelor Tablet

Ticagrelor should be avoided in patients with active bleeding or a history of brain hemorrhage. Caution is advised in liver disease, upcoming surgery, and during pregnancy or breastfeeding. Patients must inform their doctor about any existing medical conditions or medications before starting ticagrelor. Close monitoring may be required in certain cases to prevent complications. It is important to follow medical advice strictly and never adjust the dose or stop the medication without consulting a healthcare professional.

Who Should Avoid Ticagrelor?

  • Patients with a history of intracranial bleeding
  • People with active bleeding disorders (e.g., ulcers, hemophilia)
  • Pregnant or breastfeeding women (unless advised by a doctor)

Conditions Requiring Caution

  • Liver problems
  • Gout or high uric acid levels
  • Surgery or dental procedures (inform your provider you're taking Ticagrelor)

Are There Any Age Restrictions for Using Ticagrelor?

Ticagrelor is typically prescribed for adults only. It is not recommended for use in children. Clinical studies and safety data are limited for pediatric use, so healthcare providers avoid prescribing it to individuals under 18. The safety and effectiveness of ticagrelor in children have not been established. Always consult a doctor before using this medication, especially for younger patients, to ensure appropriate treatment and avoid unnecessary health risks.

Possible Interactions with Other Medications (Drug Interactions)

Ticagrelor may interact with other blood thinners, NSAIDs, certain antibiotics, antifungals, and seizure medications, increasing the risk of side effects or reducing drug effectiveness.

Ticagrelor may interact with:

  • Other blood thinners (e.g., warfarin, heparin)
  • NSAIDs (e.g., ibuprofen, naproxen)
  • Certain antibiotics and antifungals
  • Rifampin, seizure medications, or HIV protease inhibitors

Always inform your doctor of any medications or supplements you are taking.

How Should Ticagrelor Tablets Be Stored?

Ticagrelor tablets should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), away from direct sunlight, moisture, and heat. Keep the tablets in their original packaging and do not transfer them to other containers. Ensure the medicine is kept out of reach of children and pets. Do not use the tablets past their expiration date. Avoid storing in bathrooms or damp areas, as humidity can affect the tablet's effectiveness and stability.

Recommended Storage Temperature

  • Store at 20ºC to 25ºC (68ºF to 77ºF)
  • Keep away from heat, light, and moisture
  • Do not store it in the bathroom

What Happens If Ticagrelor Is Not Stored Properly?

Improper storage may reduce the medication's effectiveness. Always keep it in its original packaging and out of reach of children. Exposure to heat, moisture, or direct sunlight can cause the tablet to break down or lose potency over time. Avoid storing it in the bathroom or near a heat source. Storing ticagrelor properly ensures its safety and full therapeutic effect. Always check the label for storage instructions and expiration dates to maintain its quality.

Ticagrelor vs Clopidogrel

Ticagrelor Clopidogrel
Belongs to a class of drugs known as antiplatelet agents. It works by stopping platelets from clumping together and causing a heart attack or stroke. Belongs to a class of drugs known as antiplatelet agents. It works similarly to Ticagrelor by stopping platelets from clumping together.
Blood thinner and antiplatelet drug that increases blood flow and reduces the likelihood of a lethal blood clot. Blood thinner used alone or with aspirin to avoid serious heart and blood vessel complications in people who have had a stroke, heart attack, or extreme chest pain.
Common side effects: Nausea, dizziness, bleeding more easily, increased uric acid. Common side effects: Headache, dizziness, nausea, vomiting, stomach pain, diarrhea.

References

Ticagrelor (Oral Route) Drug Information
ScienceDirect - Contemporary Use of Ticagrelor in Interventional Practice
Book Doctor Appointment
Book Free Appointment

Still have questions? Speak with our experts now!

040-68334455

Frequently Asked Questions

Ticagrelor is a blood thinner and antiplatelet drug. It increases the flow of blood into your veins, reducing the likelihood of potentially lethal blood clots.

Ticagrelor 90 mg functions as a blood thinner and antiplatelet drug, promoting increased blood flow and reducing the risk of developing dangerous blood clots.

Ticagrelor (Brilinta) is typically used for 6 to 12 months or longer after a stent placement or heart attack. It is prescribed alongside low-dose aspirin to prevent blood clot formation.

No, Ticagrelor is not an anticoagulant. It is an antiplatelet medication that inhibits platelet aggregation, reducing the risk of blood clot formation.

Common side effects of Ticagrelor include nausea, dizziness, increased susceptibility to bleeding, and elevated levels of uric acid in the body.

Ticagrelor is not an anticoagulant but an antiplatelet medication. It helps prevent blood clots by stopping platelets from sticking together, reducing the risk of heart attacks and strokes.


Disclaimer: The information provided is accurate and up-to-date to the best of our knowledge. However, it should not be considered a substitute for medical advice or consultation. We do not guarantee its completeness or accuracy. The absence of specific warnings does not mean a medicine is safe for all users. We are not responsible for any outcomes based on this information and strongly recommend consulting a doctor for any medical concerns or questions.

Book Appointment Second Opinion WhatsApp Health Packages Find Doctors

Feeling unwell?

Request a callback!